← Back
Data updated: Mar 10, 2026
ARCUTIS
DermatologyImmunology
ARCUTIS is a pharmaceutical company focused on Dermatology, Immunology. Key products include ZORYVE.
2022
Since
1
Drugs
-
Trials
4
Approved (2yr)
Recent Activity
ZORYVE 2025-10-04
Efficacy
ZORYVE 2025-05-22
Efficacy
ZORYVE 2024-07-09
Efficacy
ZORYVE 2024-06-12
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 51%
1 drugs Phase 3: 5 Phase 2: 4 Phase 1: 2
Immunology 49%
1 drugs Phase 3: 4 Phase 2: 5 Phase 1: 3
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-07-29
- Latest
- 2025-10-04
- Applications
- 2